Showing results (231-240 of 682) with videos related to

Sort By:
Pageof 69
Cancer|February 25, 2003
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.
Leukemia Research|November 5, 2017
JAK2V617F detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosisPaolo Strati, Christopher B Benton, Taghi Manshouri, et al.
Cancer Research|November 5, 2002
Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell lineClara Ricci, Barbara Scappini, Vladimir Divoky, et al.
Cancer|October 29, 2009
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndromeAli Al Ameri, Charles Koller, Hagop Kantarjian, et al.
Leukemia Research|September 3, 2013
Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcomeMohamad Cherry, Marylou Cardenas-Turanzas, Hannah Pham, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemiaYesid Alvarado, Jorge Cortes, Srdan Verstovsek, et al.
American Journal of Hematology|November 5, 2019
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survivalMusa Yilmaz, Hagop Kantarjian, Xuemei Wang, et al.
Hematological Oncology|April 3, 2022
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignanciesTariq I Mughal, Naveen Pemmaraju, Rafael Bejar, et al.
Anticancer Research|December 1, 2010
c-Kit expression and mutations in phyllodes tumors of the breastPrithviraj Bose, S Terence Dunn, Jian Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2021
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 × 109/L): Final Analysis of an Open-Label Phase 2 StudyMoshe Talpaz, Josef Prchal, Lawrence Afrin, et al.
Pageof 69